ClinicalTrials.Veeva

Menu

Assessment of Color Vision in Diabetic Patients

I

Instituto de Olhos de Goiania

Status

Completed

Conditions

Retinopathy, Diabetic

Treatments

Drug: lucentis

Study type

Observational

Funder types

Other

Identifiers

NCT03345667
TRABALHO PEDRO ARVO 2018

Details and patient eligibility

About

Assessment of color vision in diabetic patients before and after the use of anti-vegf in the treatment of diabetic macular edema

Enrollment

30 patients

Sex

All

Ages

1 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Having diabetic retinopathy with macular edema

Exclusion criteria

  • Not having diabetic retinopathy with macular edema

Trial design

30 participants in 1 patient group

Anti-Vegf
Description:
Use intravitreous anti-vegf
Treatment:
Drug: lucentis

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems